Business Context and Reporting Period
This Form 8-K filing by Oaktree Acquisition Corp. III Life Sciences (the "Company") reports events occurring on October 30, 2024, following its Initial Public Offering (IPO) on October 25, 2024. The Company is a Cayman Islands corporation focused on the life sciences sector, with securities trading on The Nasdaq Stock Market LLC under symbols OACCU, OACC, and OACCW.
Key Financial Metrics and Capital Events
- Over-Allotment Exercise: Underwriters partially exercised their over-allotment option, purchasing 1,699,029 Public Units at $10.00 per unit.
- Proceeds from Over-Allotment: Generated additional gross proceeds of $16,990,290.
- Additional Private Placement: The Sponsor purchased 33,981 Additional Private Placement Units at $10.00 per unit.
- Proceeds from Private Placement: Generated additional gross proceeds of $339,810.
- Total Base Offering Proceeds: Combined with the initial IPO, $175,000,000 was placed in a trust account for public shareholders.
- Share Forfeiture: As a result of the partial over-allotment exercise, the Sponsor forfeited 231,492 Class B ordinary shares at no cost to the Company.
- Unaudited Pro Forma Balance Sheet: Filed as Exhibit 99.1 to reflect the receipt of proceeds from the October 30 transactions. The filing explicitly states this is for illustrative purposes only and has not been audited.
Material Changes Versus Prior Period
The primary material change is the increase in capital raised and the adjustment to the share count following the partial exercise of the over-allotment option. The underwriters forfeited the right to purchase the remaining 925,971 Public Units available under the option. Consequently, the total number of Public Units sold increased from the initial 17,500,000 to 19,199,029.
Guidance, Outlook, and Risks
- Management Commentary: The filing confirms the successful consummation of the IPO and the partial over-allotment. No specific operational guidance or future earnings outlook is provided, as is typical for a Special Purpose Acquisition Company (SPAC) in the pre-business combination phase.
- Risks and Contingencies: The Company warns that the unaudited pro forma balance sheet is not indicative of the historical or future financial position and should not be relied upon as such. The independent registered public accounting firm has not audited or reviewed the pro forma data.
- Unusual Items: The forfeiture of 231,492 Class B ordinary shares by the Sponsor is a direct result of the partial exercise of the over-allotment option, a standard mechanism in SPAC IPOs to align sponsor equity with public share issuance.
Investor Verification Checklist
- Verify the final total number of Public Units outstanding (19,199,029) and the corresponding trust account balance.
- Confirm the status of the remaining 925,971 Public Units under the over-allotment option (forfeited).
- Review the unaudited pro forma balance sheet (Exhibit 99.1) to understand the immediate post-transaction capital structure, noting it is unaudited.
- Monitor future filings for the identification of a target business combination, as the Company is currently in the SPAC formation phase.